Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Cardiac arrest; This is a spontaneous report from a contactable physician downloaded from the regulatory authority-WEB FR-AFSSAPS-LY20211241. An 87-year-old male patient received second dose of BNT162B2 (COMIRNATY, Solution for injection, Lot Number: ER0641), intramuscular at right arm on 19Feb2021 (at unknown age) at single dose for COVID-19 immunisation. Medical history included calcified aortic stenosis, Carotid artery stenosis, both were from an unknown date and unknown if ongoing. No previous history of SARS-CoV-2 infection. The patient''s concomitant medications were not reported. The patient previously took first dose of BNT162B2 (COMIRNATY, Solution for injection, Batch/Lot Number not provided) for COVID-19 immunisation. No long-standing treatment was reported. On 24Feb2021, the patient developed cardiac arrest requiring emergency intervention. The patient died on 24Feb2021 as a result of the disease (Not otherwise specified). The patient had Emergency room visit. Seriousness criteria of the case was reported as adverse event leading to death. It was unknown if an autopsy was performed. No FU attempts possible. No further information expected.; Reported Cause(s) of Death: Cardiac arrest
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166